Shikiar Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,760
Closed -$400K 81
2025
Q1
$400K Sell
5,760
-90,399
-94% -$7.47M 0.12% 61
2024
Q4
$8.27M Sell
96,159
-15,085
-14% -$1.63M 2.19% 16
2024
Q3
$13.2M Sell
111,244
-16,791
-13% -$2.24M 3.48% 6
2024
Q2
$18.3M Sell
128,035
-1,805
-1% -$239K 4.89% 4
2024
Q1
$16.7M Buy
129,840
+2,800
+2% +$333K 4.87% 5
2023
Q4
$13.1M Buy
127,040
+18,921
+18% +$1.87M 4.07% 9
2023
Q3
$9.83M Buy
108,119
+58,179
+116% +$5.13M 3.42% 9
2023
Q2
$4.04M Buy
+49,940
New +$4.08M 1.3% 21
2017
Q3
Sell
-10,000
Closed -$214K 110
2017
Q2
$214K Sell
10,000
-14,000
-58% -$283K 0.09% 103
2017
Q1
$411K Hold
24,000
0.19% 74
2016
Q4
$430K Buy
24,000
+9,000
+60% +$163K 0.19% 69
2016
Q3
$312K Hold
15,000
0.14% 91
2016
Q2
$403K Hold
15,000
0.18% 82
2016
Q1
$406K Buy
+15,000
New +$402K 0.19% 80

Other funds holding NVO

Shikiar Asset Management's NVO Position: Q2 2025 in Review

Shikiar Asset Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 5,760 shares — an estimated $400K sold.

Shikiar Asset Management first reported a position in NVO in Q1 2016 and held it in 14 quarters. The position peaked at $18.3M in Q2 2024. 1,482 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Shikiar Asset Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Shikiar Asset Management sold 5,760 Novo Nordisk shares in Q2 2025, an estimated $400K.
  • Shikiar Asset Management first reported a position in Novo Nordisk in Q1 2016 and held it in 14 quarters.
  • Shikiar Asset Management's Novo Nordisk position peaked at $18.3M in Q2 2024.
  • 1,482 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Shikiar Asset Management's 13F filing for Q2 2025, filed 24 Jul 2025.